Grant of Options
Updated : 14:28
29 October 2021
Quixant plc
("Quixant" or the "Company")
Grant of Options
Quixant (AIM:QXT), a leading provider of innovative, highly engineered technology products principally for the global gaming and broadcast industries, announces that on 25 October 2021 the Board granted a total of 125,000 options ("Options") over ordinary shares of 0.1 pence each in the capital of the Company ("Ordinary Shares") to Johan Olivier, Chief Financial Officer of the Company, as follows:
Number of Shares | Exercise price |
100,000 | 190p |
25,000 | 0.1p |
The Options are exercisable from the date of the release of the Company's accounts for the year ending 31 December 2023. The Options are exercisable subject to the growth of the diluted earnings per Ordinary Share (as set out in each of the audited accounts for the years ending 31 December 2021, 2022 and 2023) being equal to or greater than 10 per cent in each financial year.
Following the Grant, there are a total of 1,314,790 Options outstanding, representing approximately 2% of the current issued share capital of the Company.
Further detail is set out in the PDMR disclosure table below.
Quixant plc Jon Jayal, Chief Executive Officer Johan Olivier, Chief Financial Officer
| Tel: +44 (0)1223 892 696 |
Nominated Adviser and Broker: finnCap Ltd Matt Goode / Simon Hicks (Corporate Finance) Alice Lane (ECM)
| Tel: +44 (0) 20 7220 0500 |
Joint Broker: Canaccord Genuity Limited Simon Bridges / Andrew Potts
| Tel: +44 (0) 20 7523 8000 |
Financial PR: Alma PR John Coles / Hilary Buchanan / Kieran Breheny | Tel: +44 (0)20 3405 0205 |
About Quixant
Quixant, founded in 2005, designs and manufactures highly optimised computing solutions and monitors principally for the global gaming and broadcast industries. The Company is headquartered in Cambridge in the UK, with offices throughout Europe, North America and Asia. Quixant has its own manufacturing and engineering operation based in Taiwan and software engineering and customer support teams based in Italy and Slovenia. All the specialised products software and manufacturing are produced in-house and Quixant owns all its own IP some of which is protected by patents and design rights.
In November 2015 Quixant acquired Densitron Technologies plc. Densitron has a strong heritage in the sale of electronic display solutions to global industrial markets. Through Densitron's experienced sales team, Quixant has a robust platform to build its business into wider industrial markets. In-depth information on the Company's products, markets, activities and history can be found on the corporate website at www.quixant.com.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1. | Details of the person discharging managerial responsibilities/person closely associated | |||||||
a) | Name: | Johan Olivier | ||||||
2. | Reason for the notification | |||||||
a) | Position/status: | Chief Financial Officer | ||||||
b) | Initial notification/Amendment: | Initial Notification | ||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a) | Name: | Quixant plc | ||||||
b) | LEI: | 2138003VERSWQP561X71 | ||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
a) | Description of the financial instrument, type of instrument: Identification code: | Options over Ordinary shares of 0.1p
GB00B99PCP71 | ||||||
b) | Nature of the transaction: | Purchase of ordinary shares of 0.1p | ||||||
c) | Price(s) and volume(s): |
| ||||||
d) | Aggregated information: · Aggregated volume: · Price: | See 4 (c) | ||||||
e) | Date of the transaction: | 25 October 2021 | ||||||
f) | Place of the transaction: | Off market transaction |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.